NCT06506435 Radiotherapy Patient Education With Virtual Reality
| NCT ID | NCT06506435 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-12-04 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2024-12-04 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study is to investigate the impact of virtual reality experiences on individuals undergoing radiotherapy, aiming to assess whether this immersive technology can reduce anxiety and enhance patient overall treatment satisfaction. By comparing different virtual reality techniques and a standard informational video, the study seeks to identify optimal strategies for leveraging virtual reality to improve the patient experience during radiotherapy.
Eligibility Criteria
Inclusion Criteria: 1. Histologically proven cancer 2. ≥18 years of age 3. Able to speak and read English and/or Spanish 4. Receiving radiotherapy at the University of Miami Exclusion Criteria: 1. Prior radiation therapy 2. Pregnant or nursing women 3. Men or women of childbearing potential who are unwilling to employ adequate contraception 4. Patients unable to consent or are prisoners 5. Participants with impaired decision-making capacity 6. Any serious illness or medical condition that would compromise patient safety during virtual reality as judged by the treating physician 7. Unwilling or unable to watch virtual reality video 8. Unwilling to fill out survey forms
Contact & Investigator
Benjamin J Rich, MD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT06506435 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06506435 currently recruiting?
Yes, NCT06506435 is actively recruiting participants. Contact the research team at brich@miami.edu for enrollment information.
Where is the NCT06506435 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT06506435 clinical trial?
NCT06506435 is sponsored by University of Miami. The principal investigator is Benjamin J Rich, MD at University of Miami. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.